Hint mode is switched on Switch off
For swift navigation between sections

Grunenthal
LEI 529900SH895E31PGLA72

Organization name
Grunenthal GmbH
Country name
Germany
Country of registration
Germany
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
979 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Grunenthal is a pharmaceutical company headquartered in Aachen in Germany. The company was founded in 1946 as Chemie Grunenthal and has been continuously family-owned. The company was the first to introduce penicillin into the German market in the postwar period

Awards

Documentation

IFRS/US GAAP reports

2024
2023
2022
2021
2020
2019
2018
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    529900SH895E31PGLA72
Registration is required to get access.